American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 885-892 , June 2008

Association of Hepatitis C Virus Infection With Prevalence and Development of Kidney Disease

  • Sharon M. Moe, MD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • Roudebush VAMC, Indianapolis, IN
    • Corresponding Author InformationAddress correspondence to Sharon M. Moe, MD, Professor of Medicine, Vice-Chair for Research, Department of Medicine, Indiana University School of Medicine, 1001 W 10th St, OPW 526, Indianapolis, IN 46202.
    • ,
  • A.J. Pampalone, MD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • ,
  • Susan Ofner, MS

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • ,
  • Marc Rosenman, MD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • Regenstrief Institute, Indianapolis, IN.
    • ,
  • Evgenia Teal, MS

      Affiliations

    • Regenstrief Institute, Indianapolis, IN.
    • ,
  • Siu L. Hui, PhD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • Regenstrief Institute, Indianapolis, IN.

Received 15 August 2007 ,Accepted 10 March 2008.

References 

  1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562
  2. Tsui JI, Vittinghoff E, Shlipak MG, O'Hare AM. Relationship between hepatitis C and chronic kidney disease: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2006;17:1168–1174
  3. Leigh JP, Bowlus CL, Leistikow BN, Schenker M. Costs of hepatitis C. Arch Intern Med. 2001;161:2231–2237
  4. Gumber SC, Chopra S, Hepatitis C. A multifaceted disease (Review of extrahepatic manifestations). Ann Intern Med. 1995;123:615–620
  5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  6. National Kidney Foundation. K/DOQI: Part 4, Definition and classification of stages of chronic kidney disease. Am J Kidney Dis. 2002;39(suppl 1):S46–S75
  7. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–470
  8. Sabry AA, Sobh MA, Irving WL, et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transplant. 2002;17:239–245
  9. Stehman-Breen C, Alpers CE, Fleet WP, Johnson RJ. Focal segmental glomerular sclerosis among patients infected with hepatitis C virus. Nephron. 1999;81:37–40
  10. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol. 1995;44:141–147
  11. Gonzalo A, Fernandez M, Navarro J, Ortuno J. Searching for hepatitis C virus antibodies in chronic primary glomerular diseases. Nephron. 1995;69:96
  12. Liangpunsakul S, Chalasani N. Relationship between hepatitis C and microalbuminuria: Results from the NHANES III. Kidney Int. 2005;67:285–290
  13. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med. 2007;167:1271–1276
  14. Soma J, Saito T, Taguma Y, et al. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol. 2000;11:690–699
  15. Crook ED, Penumalee S, Gavini B, Filippova K. Hepatitis C is a predictor of poorer renal survival in diabetic patients. Diabetes Care. 2005;28:2187–2191
  16. Kasuno K, Ono T, Matsumori A, et al. Hepatitis C virus-associated tubulointerstitial injury. Am J Kidney Dis. 2003;41:767–775
  17. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol. 2005;140:498–506
  18. McDonald CJ, Overhage JM, Tierney WM, et al. The Regenstrief Medical Record System: A quarter century experience. Int J Med Inform. 1999;54:225–253
  19. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2003;18:967–976
  20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
  21. Tierney WM, Brunt M, Kesterson J, Zhou XH, L'Italien G, Lapuerta P. Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med. 2004;2:209–217
  22. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: Improving global outcomes. Kidney Int. 2004;66:1310–1314
  23. Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C. Lancet. 2002;359:1478–1483
  24. Broumand B, Hakemi MS, Sabet MS. Impact of hepatitis C virus infection on short-term outcomes in renal transplantation. Exp Clin Transplant. 2004;2:242–245

 Originally published online as doi:10.1053/j.ajkd.2008.03.009 on April 28, 2008.

PII: S0272-6386(08)00583-0

doi: 10.1053/j.ajkd.2008.03.009

American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 885-892 , June 2008

Article Tools